Navigation Links
Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
Date:5/9/2008

rence call; open to all interested parties, on Friday, May 9, 2008 beginning at 8:00 AM EDT. The number to call within the United States and Canada is (877) 397-0297. Participants outside the United States and Canada should call (719) 325-4913. A replay of the conference call will be available from two hours after the call through midnight EDT on May 23, 2008 and can be accessed by dialing (888) 203-1112 from within the United States and Canada or (719) 457-0820 from outside the United States and Canada. The replay ID number is 6773545.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. The Company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-F

Forward-Looking Statements

This press release contains forward-looking statements, including statements concerning our operations, our economic performance and financial condition, and our business plans and growth strategy and product development efforts. These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words "may," "might," "will," "should," "estimate," "project," "plan," "anticipate," "expect," intend," "outlook," "believe" and other similar expressions are intended to identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based on estimates and assumptions by our management that, although we believe to be reasonable, are inherently uncertain and subject to a number of risks and uncertainties.

The following represent some, but not necessarily all, of the factors that could cause actual results to differ from
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
2. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
5. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
6. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
7. Warner Chilcott Reports the Death of Its Director James Andress
8. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
9. Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. QMed, Inc. Reports July Medicare SNP Enrollments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Discovery Laboratories, ... it has received the second $1.0M tranche under ... Research (SBIR) grant valued at up to $3.0 ... aerosolized KL4 surfactant as a potential medical countermeasure ...  Discovery Labs was awarded an initial $1.0 million ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's Pony™ NS2006L ... continuous operation up to 1500 bar. The sanitary design gauge of the NS2006L ... contamination. , The Pony™ NS2006L homogenizer is an ideal solution for the processing ...
(Date:7/29/2015)... Sanofi, un leader mondial ... pour le premier semestre 2015. Le Directeur Général ... Visionner l,interview vidéo et lire la transcription ... Au sommaire de l,interview :  - ... - Diabète - Praluent ...
(Date:7/29/2015)... 2015 US-Australian drug discovery company, Novogen Limited ... is committed to progressing its ground-breaking technology platforms to ... to ensure the Company delivers the best value for ... Ross , said the Company currently had an extensive ... discovery programs and academic partnerships and initiatives, and he ...
Breaking Biology Technology:Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... ... ... ... ...
... Recycle. We hear this mantra,time and again. When it ... changenature has got reuse and recycle covered. However, it,s ... are trying to meet,this challenge by learning more about ... moves from the atmosphere into plants, oceans, soils, the,earth,s ...
... of researchers, including 10 from Texas A&M University, have for ... have been in existence immediately after the creation of the ... lead to new questions and answers about some of the ... new form of matter. Researchers Carl Gagliardi, Saskia Mioduszewski, ...
Cached Biology Technology:China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 2China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 3China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 4China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 5China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 6China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 7China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 8China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 9China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 10China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 11China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 12China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 13China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 14China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 15China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 16China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 17China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 18China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 19China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 20China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 21Scientists discover how ocean bacterium turns carbon into fuel 2Scientists discover how ocean bacterium turns carbon into fuel 3From 2-trillion-degree heat, researchers create new matter -- and new questions 2
(Date:7/31/2015)... juli 2015 Den 10. internationale konference om ... den 22. - 25. oktober i Shenzhen ... 10-års fødselsdag i år. Siden starten i 2006 er ... på ,omik,-feltet, og er en af de mest dynamiske, ... fokuserer på nylige gennembrud og fremskridt inden for ,omik,-forskning, ...
(Date:7/31/2015)... julio de 2015 BGI llevará a cabo la ... 22 al 25 de octubre de 2015, en ... celebra su décimo aniversario este año. Desde su inauguración ... las reuniones anuales más influyentes del mundo en los ... conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... , 31 de julho de 2015 A ... www.icg-10.org ) será realizada pela BGI de 22-25 de outubro ... A conferência está celebrando seu 10 o. ... a ICG se tornou uma das reuniões mais influentes ... encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... ate sourdough bread in ancient times and it,s remained ... and regions. Now Baltic scientists have reinvented this centuries-old ... a three-year long EUREKA project. Many European supermarkets ... French baguette through to the Italian ciabatta and Germany,s ...
... reconstruction of ozone levels over the Iberian Peninsula between ... years after the ratification of the Montreal Protocol. Furthermore, ... lost ozone thanks to tropospheric ozone, a secondary pollutant ... for Environmental Studies and the University of Granada have ...
... Researchers at the Swedish medical university Karolinska Institutet ... blood protein EPO are involved in the development of ... tumours proliferate in the body. These new preclinical findings ... problems of resistance that exist with many drugs in ...
Cached Biology News:Old recipe making a come back 2Old recipe making a come back 3Ground-level ozone pollution helped to recover normal ozone levels over the Iberian Peninsula 2Blood protein EPO involved in origin and spread of cancer 2
Abgene's ALTO-8 is the first automated decapper/capper for Abgene Twist-Lock tubes....
... combines 2 products into 1:, , A ... isolation kit , ,The FastPrep System ... Qbiogene/BIO101 System Matrix and Isolation Kits. Samples ... tubes eliminating the use of metal probes ...
... BR4i refrigerated multifunction centrifuges are equally capable of ... low sound level with a large range of ... rotor exchange system without tools ensures that the ... Instant rotor exchange (5 sec.) ...
... refrigerators: ,Each upright model provides fast ... temperature uniformity for refrigerated blood. The BBR25 ... Module for complete blood storage monitoring. Models ... with the HemaPro 101 alarm/monitor. All of ...
Biology Products: